İnci Alacacıoğlu

597 total citations
46 papers, 383 citations indexed

About

İnci Alacacıoğlu is a scholar working on Hematology, Genetics and Oncology. According to data from OpenAlex, İnci Alacacıoğlu has authored 46 papers receiving a total of 383 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Hematology, 14 papers in Genetics and 13 papers in Oncology. Recurrent topics in İnci Alacacıoğlu's work include Multiple Myeloma Research and Treatments (8 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (8 papers) and Lymphoma Diagnosis and Treatment (5 papers). İnci Alacacıoğlu is often cited by papers focused on Multiple Myeloma Research and Treatments (8 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (8 papers) and Lymphoma Diagnosis and Treatment (5 papers). İnci Alacacıoğlu collaborates with scholars based in Türkiye, United States and Australia. İnci Alacacıoğlu's co-authors include Fatih Demırkan, Mehmet Ali Özcan, Ahmet Alacacıoğlu, Bülent Ündar, Ömür Gökmen Sevindik, Güner Hayri Özsan, Ahmet Dirican, Bahriye Payzın, Ünsal Yılmaz and Hayri Özsan and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and Journal of Thrombosis and Haemostasis.

In The Last Decade

İnci Alacacıoğlu

43 papers receiving 376 citations

Peers

İnci Alacacıoğlu
Omer Jamy United States
Jane Jijun Liu United States
Salvatore Leotta Italy
Ajay Major United States
Gary Crouch United States
Alev Türker Türkiye
Tanya Watt United States
Giacomo Loseto Italy
Carolyn Fein Levy United States
Michael Schwarz-Eywill Germany
Omer Jamy United States
İnci Alacacıoğlu
Citations per year, relative to İnci Alacacıoğlu İnci Alacacıoğlu (= 1×) peers Omer Jamy

Countries citing papers authored by İnci Alacacıoğlu

Since Specialization
Citations

This map shows the geographic impact of İnci Alacacıoğlu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by İnci Alacacıoğlu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites İnci Alacacıoğlu more than expected).

Fields of papers citing papers by İnci Alacacıoğlu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by İnci Alacacıoğlu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by İnci Alacacıoğlu. The network helps show where İnci Alacacıoğlu may publish in the future.

Co-authorship network of co-authors of İnci Alacacıoğlu

This figure shows the co-authorship network connecting the top 25 collaborators of İnci Alacacıoğlu. A scholar is included among the top collaborators of İnci Alacacıoğlu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with İnci Alacacıoğlu. İnci Alacacıoğlu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Alacacıoğlu, İnci, et al.. (2024). The Effect of Age on High-Dose Therapy with Autologous Stem Cell Support in Multiple Myeloma: A Single-Center Experience. Journal of Clinical Medicine. 13(14). 4142–4142.
3.
Bengı, Göksel, et al.. (2021). Evaluation of using fresh frozen plasma for patients with cirrhosis at a tertiary healthcare center in Turkey: Strict transfusion policies are essential. Transfusion and Apheresis Science. 60(6). 103247–103247. 1 indexed citations
4.
Şengün, İhsan Şükrü, et al.. (2021). Therapeutic plasma exchange in neurological diseases: Eleven years experience at a tertiary care center in Turkey. Therapeutic Apheresis and Dialysis. 26(2). 465–470. 7 indexed citations
5.
Yüce, Zeynep, et al.. (2021). Assessment of Bone Marrow Biopsy and Cytogenetic Findings in Patients with Multiple Myeloma. Turkish Journal of Hematology. 39(2). 109–116. 1 indexed citations
6.
7.
Alacacıoğlu, İnci, Ayça Erşen Danyeli, Ömür Gökmen Sevindik, et al.. (2019). Prognostic Factors in Elderly Patients With Diffuse Large B-Cell Lymphoma and Their Treatment Results. Turkish Journal of Hematology. 36(2). 81–87. 4 indexed citations
8.
Sevindik, Ömür Gökmen, Faize Yüksel, Mehmet Ali Özcan, et al.. (2018). Does Reinfusion of Stem Cell Products on Multiple Days Affect Engraftment?. Turkish Journal of Hematology. 35(4). 271–276. 3 indexed citations
9.
Sevindik, Ömür Gökmen, İnci Alacacıoğlu, Mehmet Ali Özcan, et al.. (2018). A Comparison of Fresenius Com.Tec Cell and Spectra Optia Cell Separators for Autologous and Allogeneic Stem Cell Collections: Single Center Experience. Indian Journal of Hematology and Blood Transfusion. 34(4). 677–683. 3 indexed citations
10.
Tüfekçi, Özlem, et al.. (2018). Long-Term Follow-Up of a Case with Dyskeratosis Congenita Caused by NHP2-V126M/X154R Mutation: Genotype-Phenotype Association. Acta Haematologica. 141(1). 28–31. 5 indexed citations
11.
Sevindik, Ömür Gökmen, İnci Alacacıoğlu, Mehmet Ali Özcan, et al.. (2015). IPSET-Thrombosis Better Identifies Thrombosis-Free Survival: A Turkish Cohort. Clinical Lymphoma Myeloma & Leukemia. 15(6). e101–e104. 4 indexed citations
12.
Alacacıoğlu, Ahmet, Umut Varol, Tarık Salman, et al.. (2015). Depression, Anxiety and Sexual Satisfaction in Breast Cancer Patients and their Partners-Izmir Oncology Group Study. Asian Pacific Journal of Cancer Prevention. 15(24). 10631–10636. 35 indexed citations
13.
Sevindik, Ömür Gökmen, İnci Alacacıoğlu, Güner Hayri Özsan, et al.. (2015). Hypoalbuminemia is a surrogate biomarker of poor prognosis in myelodysplastic syndrome even when adjusting for comorbidities. Leukemia & lymphoma. 56(9). 2552–2555. 6 indexed citations
14.
Alacacıoğlu, İnci, Güner Hayri Özsan, Bahriye Payzın, et al.. (2014). Is the BFM Regimen Feasible for the Treatment of Adult Acute Lymphoblastic Leukemia? A Retrospective Analysis of the Outcomes of BFM and Hyper-CVAD Chemotherapy in Two Centers. Chemotherapy. 60(4). 219–223. 23 indexed citations
15.
Alacacıoğlu, Ahmet, Umut Varol, Tuğba Yavuzşen, et al.. (2014). Sexual satisfaction, anxiety, depression and quality of life in testicular cancer survivors. Medical Oncology. 31(7). 43–43. 19 indexed citations
16.
Payzın, Bahriye, et al.. (2014). JAK2 V617F Mutation Status of 232 Patients Diagnosed With Chronic Myeloproliferative Neoplasms. Clinical Lymphoma Myeloma & Leukemia. 14(6). 525–533. 11 indexed citations
17.
Akıncı, Barış, Tevfik Demir, Serkan Yener, et al.. (2008). Gestational diabetes has no additional effect on plasma thrombin-activatable fibrinolysis inhibitor antigen levels beyond pregnancy. Diabetes Research and Clinical Practice. 81(1). 93–96. 10 indexed citations
18.
Alacacıoğlu, İnci, Şermin Özkal, Muhıt Özcan, et al.. (2008). A patient with diffuse large B-cell non-Hodgkin's lymphoma and AA type amyloidosis.. PubMed. 13(1). 113–6. 2 indexed citations
19.
Özcan, Mehmet Ali, et al.. (2007). Plasma Thrombin Activitable Fibrinolysis Inhibitor Levels in Behçet´s Disease. DergiPark (Istanbul University). 2 indexed citations
20.
Demırkan, Fatih, İnci Alacacıoğlu, Hayri Özsan, et al.. (2007). The clinical, haematological and morphological profile of patients with myelodysplastic syndromes: A single institution experience from Turkey. Leukemia & lymphoma. 48(7). 1372–1378. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Omer Jamy Breakdown of academic impact, for papers by Jane Jijun Liu Breakdown of academic impact, for papers by Salvatore Leotta Breakdown of academic impact, for papers by Ajay Major Breakdown of academic impact, for papers by Gary Crouch Breakdown of academic impact, for papers by Alev Türker Breakdown of academic impact, for papers by Tanya Watt Breakdown of academic impact, for papers by Giacomo Loseto Breakdown of academic impact, for papers by Carolyn Fein Levy Breakdown of academic impact, for papers by Michael Schwarz-Eywill
Rankless by CCL
2026